Blood Pressure Drug Recalled Over Metal Contamination Fears
Blood Pressure Drug Recalled Over Metal Contamination

Breckenridge Pharmaceutical, Inc. has voluntarily recalled a batch of its 60mg propranolol hydrochloride extended-release capsules over fears of metal contamination. The recall, announced on Monday, November 16, was published by the US Food and Drug Administration.

The affected bottles contain 100 capsules each and are stamped with batch number PK25110035, with an expiration date of May 2029. The capsules are white with black writing.

Potential Health Risks

The company warned that use of the affected product could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine. The affected lot shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market.

Breckenridge stated it was unaware of any adverse events in connection with the recall.

Consumer Guidance

Consumers are advised to immediately stop taking product from the recalled lot and contact their physician or healthcare provider for medical advice and replacement instructions. They should return any unused portion of the affected product to the pharmacy where it was obtained.

Wholesalers, pharmacies, and other retail entities should check inventory for the recalled lot, quarantine any affected product, and not distribute or dispense it. Entities that further distributed the product should notify their sub-accounts to the retail level.

The capsules were distributed to pharmacies from October 26 until November 4.